BioSpace News Archive

Press Releases

Genentech Provides Update on Phase III persevERA Study in ER-positive Advanced Breast Cancer

March 9, 2026
·
7 min read
Press Releases

Harbour BioMed and Kelun-Biotech Announce NMPA Approval of IND Application for HBM7575/SKB575 for the Treatment of Atopic Dermatitis

March 9, 2026
·
5 min read
Press Releases

New paper in Frontiers in Medicine reveals first reliable biomarker test for early kidney transplant rejection detection in living-donor recipients

March 9, 2026
·
4 min read
Press Releases

HUTCHMED Announces Update on Licensed Oncology Product TAZVERIK® in China

March 9, 2026
·
6 min read
Press Releases

GenSight Biologics Provides Updates about GS010/LUMEVOQ® Early Access Programs and the Ongoing REVISE Study

March 9, 2026
·
3 min read
Press Releases

Naobios and SGS Partner to Manufacture Respiratory Syncytial Virus (RSV) Challenge Agent

March 9, 2026
·
2 min read
Press Releases

ARS Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Updates on neffy® (epinephrine nasal spray) Commercialization

March 9, 2026
·
19 min read
Press Releases

Chiesi Global Rare Diseases and Protalix BioTherapeutics Announce European Commission Approval of Additional Dosing Regimen of Every Four Weeks for Elfabrio® (pegunigalsidase alfa)

March 9, 2026
·
13 min read
Press Releases

IDEAYA Biosciences Announces First-Patient-In for Phase 1 Trial of IDE892, a Potential Best-In-Class PRMT5 Inhibitor for MTAP-Deleted Solid Tumors, and Provides MTAP and CDKN2A Pipeline Update

March 9, 2026
·
7 min read
Press Releases

Atamyo Therapeutics Presents Promising Results in the First Patients Treated With Its ATA-200 Gene Therapy in the Clinical Trial Targeting LGMD-R5 Limb-girdle Muscular Dystrophy

March 9, 2026
·
5 min read